Suven secures product patents in Australia, South Korea and China
These products will help in the treatment of disorders associated with neuro-degenerative diseases
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Category
Archive
‘The results are a dawn of new hope for all Indians’
What does India want from its new PM's policy on pharma industry ? Email your hopes and aspirations to:…
US FDA releases Q&A guidance on stability testing of ANDAs
Document supports June 2013 guidance on 'ANDAs: Stability Testing of Drug Substances and Products'
Kiran Mazumdar-Shaw receives coveted ‘Othmer Gold Medal 2014’ from Chemical Heritage Foundation
She gets the award for pioneering efforts in biotechnology and for scripting an entrepreneurial story by drawing on her knowledge…
GR Raghavender takes over as Director IPR, DIPP
Raghavender played a significant role in seeing the 2012 copyright amendments through
US FDA seeks further evidence on efficacy of Novartis’ RLX030
The RLX030 submission to the FDA included phase II and III efficacy and safety data from the clinical development programme,…
Drug therapy for allergy moves forward
Researchers have identified several target molecules which are suitable for the development of new allergy drugs
Employee ‘engagement’ highest among Indians: Kelly Services
The KGWI canvassed responses from approximately 230,000 people across 31 countries with more than 4,000 mid and senior level…
India and China’s prevalent cases of multiple sclerosis to witness highest growth by 2023:…
GlobalData epidemiologists forecast that the US will have the highest number of prevalent cases of MS by 2023
Cancer Genetics acquires BioServe India
The acquisition positions CGI to immediately participate in the high growth Indian molecular diagnostics and oncology services…